{"id":"whole-blood-transfusion","safety":{"commonSideEffects":[{"rate":"null","effect":"Hypersensitivity reactions"},{"rate":"null","effect":"Acute hemolysis"},{"rate":"null","effect":"Transmission of infectious diseases"}]},"_chembl":{"chemblId":"CHEMBL2108414","moleculeType":"Unknown"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"This process helps to replenish oxygen-carrying red blood cells, clotting factors, and other essential components of blood. The transfused blood can help to alleviate symptoms of anemia, bleeding disorders, and other conditions related to blood loss.","oneSentence":"Whole blood transfusion involves the transfer of whole blood from a donor into a patient to restore blood volume and red blood cell count.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T01:41:00.866Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Treatment of anemia due to blood loss or bone marrow failure"},{"name":"Treatment of bleeding disorders, such as hemophilia"},{"name":"Treatment of other conditions related to blood loss or anemia"}]},"trialDetails":[{"nctId":"NCT01553214","phase":"PHASE4","title":"Improving White Blood Cell Collection From Healthy Donors","status":"RECRUITING","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2012-12-31","conditions":"Allogeneic Granulocyte Donation","enrollment":1000},{"nctId":"NCT01306019","phase":"PHASE1, PHASE2","title":"Lentiviral Gene Transfer for Treatment of Children Older Than Two Years of Age With X-Linked Severe Combined Immunodeficiency (XSCID)","status":"RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2012-09-25","conditions":"X-linked Severe Combined Immunodeficiency (XSCID)","enrollment":40},{"nctId":"NCT05124041","phase":"NA","title":"Goal-Directed Hemostatic Resuscitation Trial in ACLF Induced Coagulopathy","status":"COMPLETED","sponsor":"Post Graduate Institute of Medical Education and Research, Chandigarh","startDate":"2021-11-15","conditions":"Acute on Chronic Liver Failure, Variceal Hemorrhage, Cirrhosis, Liver","enrollment":262},{"nctId":"NCT00023023","phase":"","title":"Study of Transfusion-Transmitted Infections","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2002-01-17","conditions":"Viral Disease, Blood Donation, Transfusion-Transmitted Infections","enrollment":1771},{"nctId":"NCT06692335","phase":"NA","title":"HIFU Versus Myomectomy for the Treatment of Symptomatic Uterine Fibroids","status":"RECRUITING","sponsor":"Chinese University of Hong Kong","startDate":"2025-02-06","conditions":"Uterine Fibroids (UF)","enrollment":112},{"nctId":"NCT07494708","phase":"NA","title":"Hemoglobin Drop and Need for Blood Transfusion in Primary Knee Arthroplasty With or Without Drain Insertion","status":"COMPLETED","sponsor":"Shifa International Hospital","startDate":"2025-08-01","conditions":"Knee Osteoarthritis, Rheumatoid Arthritis of the Knee, Post-Traumatic Arthritis of the Knee","enrollment":102},{"nctId":"NCT03910452","phase":"EARLY_PHASE1","title":"Haploidentical Transplant for People With Chronic Granulomatous Disease (CGD) Using Alemtuzumab, Busulfan and TBI With Post-Transplant Cyclophosphamide","status":"ACTIVE_NOT_RECRUITING","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2019-10-28","conditions":"Chronic Granulomatous Disease","enrollment":4},{"nctId":"NCT05949684","phase":"PHASE3","title":"ELEMENT-MDS: A Study to Compare the Efficacy and Safety of Luspatercept in Participants With Myelodysplastic Syndrome (MDS) and Anemia Not Receiving Blood Transfusions","status":"RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2023-10-24","conditions":"Myelodysplastic Syndromes","enrollment":360},{"nctId":"NCT07096297","phase":"PHASE2","title":"Luspatercept + Darbepoetin in MDS","status":"RECRUITING","sponsor":"Yale University","startDate":"2025-12-16","conditions":"MDS (Myelodysplastic Syndrome)","enrollment":60},{"nctId":"NCT03889834","phase":"NA","title":"Biological Parameters Changes After Autologous Blood Transfusion of Red Blood Cells (200 ml) in Healthy Volunteers.","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2024-01-25","conditions":"The Focus is on the Detection of the Consequences of Autologous Blood Transfusion in Healthy Volunteers","enrollment":30},{"nctId":"NCT03037164","phase":"PHASE3","title":"INTERCEPT Blood System for RBCs Study in Regions at Potential Risk for Zika Virus Transfusion-Transmitted Infections","status":"ACTIVE_NOT_RECRUITING","sponsor":"Cerus Corporation","startDate":"2017-05-11","conditions":"Anemia","enrollment":692},{"nctId":"NCT01282021","phase":"","title":"Molecular Immunohematology in Ethiopian Sub-Populations","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"2012-11-03","conditions":"Immunohematology","enrollment":95},{"nctId":"NCT06358079","phase":"NA","title":"Re-infusion of Unwashed Shed Blood During Off-pump Surgery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Damascus University","startDate":"2024-03-27","conditions":"Coronary Artery Disease, Blood Transfusion Complication, Cardiovascular Complication","enrollment":50},{"nctId":"NCT07483151","phase":"","title":"Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative Venous Congestion And Cognitive Dysfunction After Cardiac Surgery","enrollment":110},{"nctId":"NCT06916832","phase":"","title":"Evaluation of a Patient Blood Management Protocol Impact on the Transfusion Rate in Delivery Hemorrhage","status":"COMPLETED","sponsor":"Centre Hospitalier Intercommunal de Toulon La Seyne sur Mer","startDate":"2024-12-23","conditions":"Delivery Hemorrhage","enrollment":397},{"nctId":"NCT05889494","phase":"NA","title":"Autologous Whole Blood Management for Transfusion Reduction in Adult Cardiac Surgery Patients","status":"COMPLETED","sponsor":"University of Alberta","startDate":"2025-03-24","conditions":"Postoperative Hemorrhage, Postoperative Anemia, Postoperative Blood Loss","enrollment":64},{"nctId":"NCT06408597","phase":"NA","title":"Mannitol Versus Nitroglycerin for Kidney Injury Prevention in Robotic-assisted Radical Prostatectomy or Cystectomy","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nazmy Edward Seif","startDate":"2024-05-12","conditions":"Prostate Cancer, Bladder Cancer, Surgery","enrollment":90},{"nctId":"NCT07477392","phase":"NA","title":"Effect of Two Different Fluid Treatment Regimens on Ultrasonographic Upper Airway Measurements","status":"COMPLETED","sponsor":"Bozyaka Training and Research Hospital","startDate":"2023-03-01","conditions":"Goal-directed Fluid Theraphy, Upper Airway Ultrasonography","enrollment":145},{"nctId":"NCT06859424","phase":"PHASE2","title":"A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation","status":"RECRUITING","sponsor":"Center for International Blood and Marrow Transplant Research","startDate":"2025-07-25","conditions":"AML (Acute Myelogenous Leukemia), Acute Lymphoid Leukemia (ALL), Acute Leukemia (Category)","enrollment":358},{"nctId":"NCT06747546","phase":"NA","title":"Research on Circulation Management Strategy Based on Oxygen Metabolism Balance After CHD Surgery","status":"ENROLLING_BY_INVITATION","sponsor":"Children's Hospital of Fudan University","startDate":"2025-01-01","conditions":"Congenital Heart Disease (CHD), Cardiopulmonary Bypass, Children","enrollment":300},{"nctId":"NCT06763341","phase":"PHASE1","title":"A Phase 1 Study of AOH1996 in Patients With Relapsed/Refractory Acute Myeloid Leukemia","status":"RECRUITING","sponsor":"City of Hope Medical Center","startDate":"2025-07-30","conditions":"Recurrent Acute Myeloid Leukemia, Refractory Acute Myeloid Leukemia","enrollment":12},{"nctId":"NCT07458178","phase":"","title":"A New Scoring System to Predict High-Risk Groups in Upper Gastrointestinal Bleeding","status":"COMPLETED","sponsor":"Izmir Katip Celebi University","startDate":"2024-01-01","conditions":"Upper Gastrointestinal Bleeding (UGIB), High Risk Bleeding","enrollment":312},{"nctId":"NCT06872333","phase":"PHASE2","title":"Allo HSCT for High Risk Hemoglobinopathies","status":"RECRUITING","sponsor":"Masonic Cancer Center, University of Minnesota","startDate":"2024-11-19","conditions":"Graft Failure, Sickle Cell Disease, Hemoglobinopathies","enrollment":62},{"nctId":"NCT06840756","phase":"PHASE4","title":"Effects of Donor-recipient Sex-matched Blood Transfusion on Patient Outcomes","status":"RECRUITING","sponsor":"Michelle Zeller","startDate":"2025-09-11","conditions":"Red Blood Cell Transfusions, Sex Differences, Health Services","enrollment":11082},{"nctId":"NCT07466719","phase":"NA","title":"Comparison of Efficacy and Safety of Manual Syringing Versus Pneumatic Pressure Bag for Blood Transfusion in Patients Undergoing Cesarean Section With Major Obstetric Hemorrhage","status":"RECRUITING","sponsor":"Aswan University","startDate":"2025-09-01","conditions":"Obstetric Hemostasis, Intravascular Hemolysis, Major Obstetric Hemorrhage","enrollment":50},{"nctId":"NCT07465029","phase":"","title":"A Study of Incidence, Treatment Patterns, and Outcomes in Transfusion-dependent Lower-risk Myelodysplastic Syndromes in Spain","status":"ACTIVE_NOT_RECRUITING","sponsor":"Bristol-Myers Squibb","startDate":"2026-02-02","conditions":"Lower-risk Myelodysplastic Syndromes (TD LR-MDS)","enrollment":1300},{"nctId":"NCT06499285","phase":"PHASE3","title":"A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS) Who Need Regular Blood Transfusions","status":"RECRUITING","sponsor":"Takeda","startDate":"2025-05-06","conditions":"Myelodysplastic Syndromes","enrollment":225},{"nctId":"NCT03587272","phase":"PHASE2","title":"Minimizing Toxicity in HLA-identical Sibling Donor Transplantation for Children With Sickle Cell Disease","status":"RECRUITING","sponsor":"Robert Nickel","startDate":"2018-04-17","conditions":"Sickle Cell Disease","enrollment":100},{"nctId":"NCT07459491","phase":"","title":"Agreement Between ChatGPT-5 and Anesthesiologists in Preoperative Risk Assessment: ASA Classification","status":"ACTIVE_NOT_RECRUITING","sponsor":"Damla Kaytancı Özçelik","startDate":"2025-12-02","conditions":"Artifical Intelligence, Preoperative Evaluation","enrollment":703},{"nctId":"NCT07462962","phase":"","title":"Effects of Mindfulness Meditation Training on Anxiety and Sleep Quality of Patients With Hematopoietic Stem Cell Transplantation During Admission in the Laminar Flow Chamber","status":"COMPLETED","sponsor":"Henan University","startDate":"2025-03-01","conditions":"Hematopoietic Stem Cell Transplantation (HSCT), Cancer and / or Hematological Malignancy","enrollment":70},{"nctId":"NCT07457879","phase":"","title":"Impact of the Reimbursement of Fibrinogen in Cardiac Surgery","status":"NOT_YET_RECRUITING","sponsor":"Erasme University Hospital","startDate":"2026-03-20","conditions":"Cardiac Surgery","enrollment":450},{"nctId":"NCT04040023","phase":"NA","title":"Patient Blood Management in Cardiac Surgery","status":"COMPLETED","sponsor":"Clinique Pasteur","startDate":"2019-09-10","conditions":"Surgical Blood Loss","enrollment":900},{"nctId":"NCT05430659","phase":"","title":"Intraoperative Estimated Blood Loss, Blood Transfusion, and Postoperative Clinical Outcomes in Patients Undergoing Non Cardiac Surgery, Siriraj Hospital","status":"ACTIVE_NOT_RECRUITING","sponsor":"Siriraj Hospital","startDate":"2022-07-01","conditions":"General Surgery, Blood Loss, Surgical","enrollment":1268},{"nctId":"NCT00004850","phase":"","title":"Epidemiology, Infectivity and Natural History of Hepatitis C Virus Infection","status":"COMPLETED","sponsor":"National Institutes of Health Clinical Center (CC)","startDate":"1991-03-15","conditions":"Hepatitis C, Hepatitis B","enrollment":805},{"nctId":"NCT05736419","phase":"PHASE2","title":"A Study of Immune Suppression Treatment for People With Sickle Cell Disease or β-Thalassemia Who Are Going to Receive an Allogeneic Hematopoietic Cell Transplantation (HCT)","status":"RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2023-02-09","conditions":"Sickle Cell Disease, Thalassemia, Beta, Thalassemia","enrollment":24},{"nctId":"NCT05679401","phase":"PHASE3","title":"A Study With Imlifidase in Anti-GBM Disease","status":"TERMINATED","sponsor":"Hansa Biopharma AB","startDate":"2022-12-22","conditions":"Anti-Glomerular Basement Membrane Disease, Anti-Glomerular Basement Membrane Antibody Disease, Goodpasture Syndrome","enrollment":50},{"nctId":"NCT04084080","phase":"PHASE3","title":"Sickle Cell Disease and CardiovAscular Risk - Red Cell Exchange Trial (SCD-CARRE)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Pittsburgh","startDate":"2020-02-26","conditions":"Sickle Cell Disease","enrollment":173},{"nctId":"NCT07446647","phase":"PHASE1","title":"Comparative Analysis of Biotinylated, Irradiated and 51-Chromium Radiolabeled Red Blood Cells for Analysis of Recovery and Survival After Autologous Transfusion","status":"NOT_YET_RECRUITING","sponsor":"Jose Cancelas","startDate":"2026-03","conditions":"Healthy Volunteer Red Blood Cell Labeling Study; Not Disease Focused","enrollment":20},{"nctId":"NCT07432737","phase":"NA","title":"One Versus Two Doses of Tranexamic Acid in Surgically Treated Extracapsular Hip Fractures","status":"RECRUITING","sponsor":"University Hospital for Surgical Diseases St. Naum Ohridsk i- Skopje","startDate":"2026-02-17","conditions":"Hip Fractures","enrollment":120},{"nctId":"NCT07437755","phase":"NA","title":"Thrombelastometry-guided Blood Component Administration Versus Standard of Care in Patients With Decompensated Liver Cirrhosis Undergoing Invasive Procedures","status":"RECRUITING","sponsor":"Grigore T. Popa University of Medicine and Pharmacy","startDate":"2025-06-01","conditions":"Liver Cirrhosis With Acute Decompensation","enrollment":116},{"nctId":"NCT06078696","phase":"PHASE1, PHASE2","title":"Siplizumab for Sickle Cell Disease Transplant","status":"TERMINATED","sponsor":"Columbia University","startDate":"2023-09-28","conditions":"Anemia, Sickle Cell","enrollment":1},{"nctId":"NCT07436767","phase":"NA","title":"Safety and Efficacy of KL003 Cell Injection in Severe Sickle Cell Disease","status":"NOT_YET_RECRUITING","sponsor":"Institute of Hematology & Blood Diseases Hospital, China","startDate":"2026-03-01","conditions":"Sickle Cell Disease","enrollment":3},{"nctId":"NCT07420582","phase":"","title":"Antegrade Autologous Blood Reinfusion After CPB","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2026-02-23","conditions":"Coronary Artery Disease","enrollment":130},{"nctId":"NCT06070350","phase":"PHASE3","title":"Massive Transfusion in Children-2: A Trial Examining Life Threatening Hemorrhage in Children","status":"RECRUITING","sponsor":"Philip Spinella","startDate":"2024-11-01","conditions":"Hemorrhagic Shock, Trauma Injury","enrollment":1000},{"nctId":"NCT07428265","phase":"NA","title":"Comparison of Wound Healing for Diabetic Carbuncle Treated With Incision and Drainage Technique Using Cruciate Incision vs Saucerization Technique Both Followed by Vacuum Assisted Closure.","status":"RECRUITING","sponsor":"King Edward Medical University","startDate":"2026-01-02","conditions":"Carbuncle","enrollment":124},{"nctId":"NCT07425600","phase":"","title":"Individualized Dose of Fibrinogen Following Cardiopulmonary Bypass","status":"NOT_YET_RECRUITING","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2026-03-01","conditions":"Fibrinogen Deficiency in Complex Cardiac Surgery","enrollment":150},{"nctId":"NCT07420296","phase":"PHASE4","title":"Modified Zipper Therapy for AQP4-IgG Positive Neuromyelitis Optica Spectrum Disorder","status":"RECRUITING","sponsor":"Tianjin Medical University General Hospital","startDate":"2026-01-01","conditions":"Neuromyelitis Optica Spectrum Disorders (NMOSD)","enrollment":198},{"nctId":"NCT06979492","phase":"PHASE4","title":"Prophylactic Transfusion In Pregnant in Women With Sickle Cell Disease","status":"RECRUITING","sponsor":"Emory University","startDate":"2026-04","conditions":"Sickle Cell Disease, Pregnancy Related","enrollment":50},{"nctId":"NCT07341139","phase":"","title":"Blood Storage Related Mortality and Adverse Effects in Trauma Patients","status":"RECRUITING","sponsor":"Kocaeli City Hospital","startDate":"2026-01-17","conditions":"Transfusion Adverse Reaction, Major Trauma, Blood Product Transfusion for All Conditions","enrollment":300},{"nctId":"NCT02201576","phase":"PHASE2","title":"Bortezomib in Rejection of Kidney Transplants","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2015-02-11","conditions":"Chronic Antibody-mediated Transplant Rejection","enrollment":60},{"nctId":"NCT03657394","phase":"NA","title":"Comparative Outcomes Related to Delivery-room Cord Milking In Low-resourced Kountries","status":"ACTIVE_NOT_RECRUITING","sponsor":"Nemours Children's Clinic","startDate":"2022-10-17","conditions":"Hypoxic-Ischemic Encephalopathy, Birth Asphyxia","enrollment":3442},{"nctId":"NCT06710418","phase":"NA","title":"Evaluating the Effects of Hemoglobin Threshold-specific Packed Red Blood Cell Transfusions on Quality of Life and Functional Outcomes in Patients With High-grade Myeloid Neoplasms, Acute Myeloid Leukemia, or B Acute Lymphoblastic Lymphoma/Leukemia","status":"RECRUITING","sponsor":"University of Washington","startDate":"2025-10-15","conditions":"Acute Myeloid Leukemia, B Acute Lymphoblastic Leukemia, B Lymphoblastic Lymphoma","enrollment":50},{"nctId":"NCT04684719","phase":"PHASE3","title":"Type O Whole Blood and Assessment of Age During Prehospital Resuscitation Trial","status":"COMPLETED","sponsor":"Jason Sperry","startDate":"2022-04-19","conditions":"Hemorrhagic Shock, Traumatic Injury","enrollment":1020},{"nctId":"NCT07328191","phase":"NA","title":"Quality of Life-Guided Transfusion in Refractory MDS or AML","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nice","startDate":"2026-02-09","conditions":"MDS, AML, Adult, Anemia","enrollment":52},{"nctId":"NCT07157839","phase":"","title":"Phosphorylated Tau Levels in Donated Blood","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-08-28","conditions":"Alzheimer&Amp;#39;s Disease","enrollment":250},{"nctId":"NCT07399275","phase":"","title":"Submental Tissue Oxygenation and Arterial Lactate in Major Surgery","status":"NOT_YET_RECRUITING","sponsor":"Bursa Sevket Yilmaz Training and Research Hospital","startDate":"2026-02-15","conditions":"Microcirculatory Dysfunction, Tissue Hypoperfusion, Microcirculatory Status","enrollment":150},{"nctId":"NCT05136794","phase":"","title":"LIdocaine veRsus Sufentanil Anaesthesia in Cardiac Surgery With Cardiopulmonary Bypass","status":"COMPLETED","sponsor":"Centre Hospitalier Universitaire Dijon","startDate":"2021-12-01","conditions":"Opioid Free Anaesthesia, Opioid Anaesthesia","enrollment":1772},{"nctId":"NCT02741648","phase":"","title":"RBC Irradiation, Anemia and Gut Injury","status":"ACTIVE_NOT_RECRUITING","sponsor":"Emory University","startDate":"2016-07","conditions":"Anemia, Necrotizing Enterocolitis","enrollment":324},{"nctId":"NCT04419649","phase":"PHASE2","title":"A Study of Elritercept to Treat Anemia in Adults With Very Low, Low, or Intermediate Risk Myelodysplastic Syndromes (MDS)","status":"RECRUITING","sponsor":"Takeda","startDate":"2020-08-19","conditions":"Myelodysplastic Syndromes, Cytopenia","enrollment":160},{"nctId":"NCT01911871","phase":"","title":"Multicenter Observational Study on Myocardial Iron Overload in 3 Multitransfused Populations","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2012-03","conditions":"Thalassemia, Sickle Cell Disease, Myelodysplasia","enrollment":110},{"nctId":"NCT06038630","phase":"PHASE2","title":"129Xe MRI Cardiopulmonary","status":"RECRUITING","sponsor":"Bastiaan Driehuys","startDate":"2024-01-12","conditions":"Interstitial Lung Disease, Chronic Thromboembolic Pulmonary Hypertension, Acute Pulmonary Embolism","enrollment":125},{"nctId":"NCT07375563","phase":"PHASE3","title":"Chemoimmunotherapy Combined With Autologous NK Cell Therapy for Pediatric Patients With Refractory and Relapsed High-Risk Neuroblastoma and Ganglioneuroblastoma","status":"RECRUITING","sponsor":"Federal Research Institute of Pediatric Hematology, Oncology and Immunology","startDate":"2025-11-19","conditions":"Neuroblastoma (NB), Ganglioneuroblastoma","enrollment":5},{"nctId":"NCT05612919","phase":"NA","title":"Red Blood Cells From Umbilical Cord for Transfusion of Preterm Infants","status":"COMPLETED","sponsor":"Hospital Clinic of Barcelona","startDate":"2023-09-13","conditions":"Infant, Extremely Premature, Erythrocyte Transfusion, Umbilical Cord Issue","enrollment":41},{"nctId":"NCT04431999","phase":"PHASE3","title":"Evaluation of a Transfusion Therapy Using Whole Blood in the Management of Coagulopathy in Patients With Acute Traumatic Hemorrhage","status":"COMPLETED","sponsor":"Direction Centrale du Service de Santé des Armées","startDate":"2021-12-04","conditions":"Trauma, Acute Hemorrhage, Coagulopathy","enrollment":200},{"nctId":"NCT07265674","phase":"PHASE3","title":"A Study to Select a Dose Regimen (Part A) and to Investigate Overall Survival (Part B) With Nanvuranlat Compared With Physician's Best Choice in Participants Aged 18 Years or Older With Biliary Tract Cancer","status":"RECRUITING","sponsor":"J-Pharma Co., Ltd.","startDate":"2026-01","conditions":"Advanced Biliary Tract Cancer, Biliary Tract Cancer (BTC)","enrollment":480},{"nctId":"NCT04294641","phase":"PHASE2","title":"Front Line Ibrutinib Without Corticosteroids for Newly Diagnosed Chronic Graft-versus-Host Disease","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2021-05-10","conditions":"Chronic GVHD","enrollment":10},{"nctId":"NCT05740059","phase":"NA","title":"Restrictive Transfusion StratEgy Adjusted by SvO2 During Cardiac Surgery","status":"COMPLETED","sponsor":"University Hospital, Montpellier","startDate":"2023-03-14","conditions":"Cardiac Surgery, Cardiopulmonary Bypass","enrollment":676},{"nctId":"NCT03064152","phase":"NA","title":"Rotational Thromboelastometry for the Transfusion Management of Postpartum Hemorrhage After Vaginal or Cesarean Delivery","status":"TERMINATED","sponsor":"Brigham and Women's Hospital","startDate":"2017-09-01","conditions":"Postpartum Hemorrhage","enrollment":49},{"nctId":"NCT06812507","phase":"NA","title":"Evaluation of Placental Transfusion Techniques in Prevention of Prematurity Related Complications and Effect on Their Hematological Profile","status":"RECRUITING","sponsor":"Alexandria University","startDate":"2025-03-10","conditions":"Premature, Placental Transfusion","enrollment":160},{"nctId":"NCT06944067","phase":"","title":"Study to Understand the Genetic Risk of Developing an Immune Response After Blood Transfusions Among Individuals With Sickle Cell Disease","status":"RECRUITING","sponsor":"National Human Genome Research Institute (NHGRI)","startDate":"2025-06-24","conditions":"Sickle Cell Disease","enrollment":50},{"nctId":"NCT04591574","phase":"NA","title":"ABC - A Post Intensive Care Anaemia Management Trial","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Edinburgh","startDate":"2020-09-01","conditions":"Anemia Acute, Fatigue, Physical Disability","enrollment":346},{"nctId":"NCT03849443","phase":"EARLY_PHASE1","title":"Single Versus Multi-Dose Oral and Intravenous Tranexamic Acid Patients at High Risk for Blood Transfusion After Spine Surgery","status":"RECRUITING","sponsor":"Rush University Medical Center","startDate":"2019-08-26","conditions":"Open Posterior Thoracolumbar Spinal Fusion Procedure","enrollment":604},{"nctId":"NCT06743113","phase":"NA","title":"Hypoxic Red Blood Cells in Sickle Cell Anemia","status":"NOT_YET_RECRUITING","sponsor":"Hemanext","startDate":"2026-03","conditions":"Sickle Cell Anaemia, Sickle Cell Anemia Crisis, Sickle Cell Anemia in Children","enrollment":48},{"nctId":"NCT06685848","phase":"NA","title":"Comparison of Hemanext ONE® System and Conventional Red Blood Cell Transfusion","status":"RECRUITING","sponsor":"Hemanext","startDate":"2024-11-29","conditions":"Hematologic Neoplasms","enrollment":24},{"nctId":"NCT04143724","phase":"PHASE2","title":"Study of Safety & PK of Luspatercept (ACE-536) in Pediatric Participants With Beta (β)-Thalassemia","status":"RECRUITING","sponsor":"Celgene","startDate":"2019-11-07","conditions":"Beta-Thalassemia","enrollment":99},{"nctId":"NCT05399693","phase":"","title":"Platelet Transfusion Refractoriness","status":"COMPLETED","sponsor":"Institut de cancérologie Strasbourg Europe","startDate":"2022-02-02","conditions":"Platelet Transfusion Refractoriness","enrollment":50},{"nctId":"NCT07092683","phase":"","title":"Mediation Analysis in Cardiac Surgery","status":"COMPLETED","sponsor":"Second Affiliated Hospital, School of Medicine, Zhejiang University","startDate":"2025-01-01","conditions":"Anemia, Cardiac Surgery, Transfusion","enrollment":13683},{"nctId":"NCT07303088","phase":"NA","title":"Effects of L-carnitine and Coenzyme Q10 Supplementation on Oxidative Stress in Tunisian Hemodialysis Patients.","status":"COMPLETED","sponsor":"University of Sfax","startDate":"2024-06-17","conditions":"Oxidative Stress Response, Hemodialysis, End Stage Kidney Disease (ESRD)","enrollment":52},{"nctId":"NCT06060639","phase":"NA","title":"Variation of Echocardiographic Parameters After Red Blood Cell Transfusion in Emergency Department Anemic Patients","status":"RECRUITING","sponsor":"Centre Hospitalier Universitaire de Nīmes","startDate":"2023-11-09","conditions":"Anemia, Age Problem, Ultrasonography","enrollment":116},{"nctId":"NCT07309848","phase":"","title":"Hip Fracture Surgery Timing and Blood Transfusion Risk in Patients on DOACs","status":"RECRUITING","sponsor":"St. Antonius Hospital","startDate":"2025-11-01","conditions":"Blood Transfusion, Hip Fracture Surgeries, Geriatric","enrollment":374},{"nctId":"NCT06147531","phase":"PHASE2","title":"Delayed Cold-Stored Platelets -PLTS-1","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2024-06-05","conditions":"Platelets, Bleeding, Cardiopulmonary Bypass","enrollment":150},{"nctId":"NCT07285187","phase":"","title":"Venous Congestion And Delirium After Cardiac Surgery","status":"RECRUITING","sponsor":"Zhuan Zhang","startDate":"2024-11-01","conditions":"Intraoperative, Venous Congestion, Postoperative Delirium (POD)","enrollment":120},{"nctId":"NCT03828344","phase":"PHASE1","title":"Safety and Tolerability of a Single Intravenous Infusion of BX-U001 in Refractory Rheumatoid Arthritis","status":"NOT_YET_RECRUITING","sponsor":"Baylx Inc.","startDate":"2026-12-01","conditions":"Rheumatoid Arthritis","enrollment":16},{"nctId":"NCT05091684","phase":"PHASE2","title":"Administration of Fibrinogen Concentrate for Refractory Bleeding","status":"TERMINATED","sponsor":"Centre Hospitalier Universitaire de Saint Etienne","startDate":"2022-02-10","conditions":"Hematological Patients, Bleeding, Platelet Refractoriness","enrollment":1},{"nctId":"NCT07290634","phase":"","title":"Comparative Outcomes of PCC and Recombinant Activated Factor VIIa in Trauma-Associated Massive Transfusion","status":"RECRUITING","sponsor":"Zeliha Alicikus","startDate":"2026-01-30","conditions":"Thromboembolus, Massive Blood Transfusion; Thrombocytopenia, Trauma","enrollment":4},{"nctId":"NCT04833556","phase":"","title":"Perioperative Outcomes of Postpartum Hemorrhage in Patients Undergoing Cesarean Delivery","status":"COMPLETED","sponsor":"Mahidol University","startDate":"2021-04-22","conditions":"Cesarean Section Complications, Postpartum Hemorrhage, Anesthesia Complication","enrollment":649},{"nctId":"NCT02352181","phase":"NA","title":"Management of Coagulopathy During Orthotopic Liver Transplantation. Comparison Between ROTEM-based Management and Standard Biological Assessment.","status":"COMPLETED","sponsor":"Hospices Civils de Lyon","startDate":"2014-12","conditions":"Liver Transplantation","enrollment":82},{"nctId":"NCT07055503","phase":"","title":"Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients","status":"ENROLLING_BY_INVITATION","sponsor":"University Research Institute for the Study of Genetic & Malignant Disorders in Childhood","startDate":"2025-11-20","conditions":"Transfusion-dependent Beta-Thalassemia, Blood Transfusion","enrollment":30},{"nctId":"NCT07287371","phase":"PHASE4","title":"Sucrosomial Vs Intravenous Iron for Preoperative Anemia","status":"NOT_YET_RECRUITING","sponsor":"University of Rochester","startDate":"2025-12-31","conditions":"Anemia, Iron Deficiency Anemia","enrollment":75},{"nctId":"NCT07288697","phase":"NA","title":"Dose-Dependent Effects of Intraoperative Tranexamic Acid on Surgical Bleeding and Transfusion Requirements in Multilevel Thoracolumbar Spinal Surgery","status":"COMPLETED","sponsor":"Dr. Lutfi Kirdar Kartal Training and Research Hospital","startDate":"2023-11-01","conditions":"Spinal Disorders, Degenerative Spine Disease, Blood Loss, Surgical","enrollment":62},{"nctId":"NCT06562803","phase":"NA","title":"Efficacy and Safety of Cytokine Adsorption and Plasma Exchange in Patients With ACLF and Sepsis","status":"RECRUITING","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2024-09-27","conditions":"Acute-On-Chronic Liver Failure, Sepsis","enrollment":60},{"nctId":"NCT04987489","phase":"PHASE2","title":"A Study of Etavopivat in Patients With Thalassemia or Sickle Cell Disease","status":"COMPLETED","sponsor":"Forma Therapeutics, Inc.","startDate":"2022-03-28","conditions":"Sickle Cell Disease, Thalassemia","enrollment":53},{"nctId":"NCT02750150","phase":"PHASE3","title":"Freeze-dried Plasma in the Initial Management of Coagulopathy in Trauma Patients","status":"COMPLETED","sponsor":"University Hospital, Lille","startDate":"2013-07-09","conditions":"Trauma, Coagulopathy","enrollment":42},{"nctId":"NCT07121140","phase":"NA","title":"Home Blood Transfusions","status":"RECRUITING","sponsor":"Thomas Jefferson University","startDate":"2025-06-03","conditions":"Hematologic Malignancy, Myelodysplastic Syndromes, Acute Myeloid Leukemia","enrollment":30},{"nctId":"NCT01962415","phase":"PHASE2","title":"Reduced Intensity Conditioning for Non-Malignant Disorders Undergoing UCBT, BMT or PBSCT","status":"RECRUITING","sponsor":"Paul Szabolcs","startDate":"2014-02-04","conditions":"Primary Immunodeficiency (PID), Congenital Bone Marrow Failure Syndromes, Inherited Metabolic Disorders (IMD)","enrollment":100},{"nctId":"NCT04137692","phase":"NA","title":"Red Blood Cell Exchange Transfusion as a Novel Treatment for GLUT1 Deficiency Syndrome","status":"SUSPENDED","sponsor":"Weill Medical College of Cornell University","startDate":"2027-09","conditions":"Glucose Transporter Type 1 Deficiency Syndrome, GLUT1DS1","enrollment":12},{"nctId":"NCT06285604","phase":"","title":"Effect Evaluation of Different Blood Products Infusion on Neonatal Anemia","status":"ACTIVE_NOT_RECRUITING","sponsor":"Women's Hospital School Of Medicine Zhejiang University","startDate":"2024-09-10","conditions":"Neonatal Anemia","enrollment":200},{"nctId":"NCT07087860","phase":"PHASE2","title":"Therapeutic Plasma Exchange With Enfortumab Vedotin and Pembrolizumab for Treatment of Bladder Cancers","status":"RECRUITING","sponsor":"Mayo Clinic","startDate":"2025-08-01","conditions":"Metastatic Bladder Urothelial Carcinoma, Metastatic Renal Pelvis and Ureter Urothelial Carcinoma, Refractory Bladder Urothelial Carcinoma","enrollment":70},{"nctId":"NCT04540380","phase":"PHASE1","title":"Renal Allograft Tolerance Through Mixed Chimerism - SMC/MGH","status":"ACTIVE_NOT_RECRUITING","sponsor":"Massachusetts General Hospital","startDate":"2021-09-01","conditions":"Renal Failure","enrollment":20},{"nctId":"NCT06298643","phase":"","title":"Real-World Practice Patterns and Outcomes of Lower-Risk Myelodysplastic Syndrome Patients in Japan","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2023-12-22","conditions":"Lower-risk Myelodysplastic Syndromes","enrollment":177}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":401,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"phase_3","status":"active","brandName":"Whole blood transfusion","genericName":"Whole blood transfusion","companyName":"Oregon Health and Science University","companyId":"oregon-health-and-science-university","modality":"Biologic","firstApprovalDate":"","aiSummary":"Whole blood transfusion involves the transfer of whole blood from a donor into a patient to restore blood volume and red blood cell count. Used for Treatment of anemia due to blood loss or bone marrow failure, Treatment of bleeding disorders, such as hemophilia, Treatment of other conditions related to blood loss or anemia.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":1,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}